Clinical Trial Update: Sunitinib Drug Levels and Outcomes in Kidney Cancer

View source ↗

Summary

This clinical trial update reports on the relationship between sunitinib drug levels and outcomes in renal cell carcinoma (kidney cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Western Sydney Local Health District | Conditions: Renal Cell Carcinoma | Status: UNKNOWN